Further study with expanded sample size and follow-up investigations should be carried out to establish if cytokines, BDNF, and the SBM indices are involved in the process of compensating for cognitive function ahead of the onset of T2DM-related cognitive impairment. The gene discussed is BDNF; the disease is Cognitive impairment.